Cart
sales@molnova.com
YW2036
CAS No. 2131223-92-0
YW2036( —— )
Catalog No. M36036 CAS No. 2131223-92-0
YW2036 is an inhibitor of Wnt signaling pathway.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 98 | In Stock |
|
| 10MG | 148 | In Stock |
|
| 25MG | 236 | In Stock |
|
| 50MG | 326 | In Stock |
|
| 100MG | 437 | In Stock |
|
| 200MG | 581 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYW2036
-
NoteResearch use only, not for human use.
-
Brief DescriptionYW2036 is an inhibitor of Wnt signaling pathway.
-
DescriptionYW2036 (compound 2a) is a potent Wnt/β-Catenin signaling pathway inhibitor with an IC50 value of 637 nM. YW2036 can be used in research of cancer.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayWnt/Notch/Hedgehog
-
TargetWnt/beta/catenin
-
RecptorWnt/beta-catenin
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2131223-92-0
-
Formula Weight328.37
-
Molecular FormulaC20H16N4O
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCC=1N(N=CC1C(NC2=NC3=C(C=C2)C=CC=C3)=O)C4=CC=CC=C4
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Yang W, et, al. Pyrazole-4-Carboxamide (YW2065): A Therapeutic Candidate for Colorectal Cancer via Dual Activities of Wnt/β-Catenin Signaling Inhibition and AMP-Activated Protein Kinase (AMPK) Activation. J Med Chem. 2019 Dec 26;62(24):11151-11164. ?
molnova catalog
related products
-
ICG-001
ICG-001 is an antagonist of Wnt/β-catenin/TCF-mediated transcription and specifically binds to element-binding protein (CBP) with IC50 of 3 μM.
-
NRX-103095
NRX-103095 is a potent enhancer of the interaction of β-catenin with the homologous E3 ligase SCFβ-TrCP and enhances the affinity of pSer33/Ser37 β-catenin for β-TrCP with an EC50 of 163 nM.
-
Curcumol
Curcumol, a pure monomer isolated extracted from Rhizoma Curcumaeis, has antitumor activities.
